This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
CVS Health Posts Strong Q3 Earnings: How to Play the Stock Now?
by Moumi Mondal
CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.
The Zacks Analyst Blog Highlights Apple, Procter & Gamble and UnitedHealth
by Zacks Equity Research
Zacks spotlights Apple, Procter & Gamble, and UnitedHealth as analysts assess growth outlooks, margin pressures, and evolving catalysts across sectors.
Top Analyst Reports for Apple, Procter & Gamble and UnitedHealth
by Mark Vickery
Apple, Procter & Gamble, and UnitedHealth headline fresh analyst insights, with growth forecasts, cost challenges, and strategic updates driving investor focus.
Select Medical Down 5% Despite Q3 Earnings Beat on Patient Volumes
by Zacks Equity Research
SEM's Q3 earnings drop 11.5% year over year due to the rising cost of services, despite a revenue beat and raised 2025 EPS guidance.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
UnitedHealth's Q3 Beat Isn't Stopping the Bleed: Hold or Fold Now?
by Kaibalya Pravo Dey
UNH's Q3 earnings beat couldn't stop a 9.6% stock slide as rising medical costs and margin strain test investor patience.
Stock Market News for Nov 4, 2025
by Zacks Equity Research
Wall Street ended mostly higher, with the Nasdaq and the S&P 500 finishing in positive territory, as investors once again flocked to artificial intelligence (AI) stocks following the announcement of a spate of new deals.
CVS' Health Care Delivery Arm Likely to See Better Financial Results
by Moumi Mondal
CVS Health's scaled-back Oak Street expansion, clinic closures and tech investments aim to drive stronger Health Care Delivery results next year.
Does UnitedHealth Stock Have More Upside After Q3 Earnings?
by Shaun Pruitt
UnitedHealth Group's (UNH) stock hasn't received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.
Will Lower Premiums Affect Cigna's Q3 Earnings? Key Insights Here
by Zacks Equity Research
CI's Q3 results hinge on strong Evernorth growth and surging investment income, but lower premiums and rising costs may weigh on margins.